HUT72500A - Highly soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrin - Google Patents
Highly soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrinInfo
- Publication number
- HUT72500A HUT72500A HU9502251A HU9502251A HUT72500A HU T72500 A HUT72500 A HU T72500A HU 9502251 A HU9502251 A HU 9502251A HU 9502251 A HU9502251 A HU 9502251A HU T72500 A HUT72500 A HU T72500A
- Authority
- HU
- Hungary
- Prior art keywords
- cyclodextrin
- acid
- base type
- highly soluble
- complexes containing
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI930141A IT1263831B (it) | 1993-01-29 | 1993-01-29 | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9502251D0 HU9502251D0 (en) | 1995-09-28 |
| HUT72500A true HUT72500A (en) | 1996-05-28 |
| HU218796B HU218796B (hu) | 2000-12-28 |
Family
ID=11364792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9502251A HU218796B (hu) | 1993-01-29 | 1994-01-26 | Többkomponensű, bázikus gyógyszerhatóanyagot, savat és ciklodextrint tartalmazó zárványkomplexek |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5855916A (hu) |
| EP (1) | EP0681481B1 (hu) |
| JP (1) | JPH08508711A (hu) |
| KR (1) | KR960700074A (hu) |
| AT (1) | ATE228013T1 (hu) |
| AU (1) | AU691115B2 (hu) |
| BR (1) | BR9406779A (hu) |
| CA (1) | CA2154874A1 (hu) |
| CZ (1) | CZ284606B6 (hu) |
| DE (1) | DE69431747D1 (hu) |
| FI (1) | FI953590L (hu) |
| HU (1) | HU218796B (hu) |
| IL (1) | IL108460A (hu) |
| IT (1) | IT1263831B (hu) |
| NO (1) | NO952981L (hu) |
| NZ (1) | NZ261115A (hu) |
| WO (1) | WO1994016733A1 (hu) |
| ZA (1) | ZA94572B (hu) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646131A (en) * | 1994-02-22 | 1997-07-08 | The Arab Company For Drug Industries And Medical Applicances (Acdima) | Method for solubilizing drugs using cyclodextrins and carboxylic acids |
| AUPM456894A0 (en) * | 1994-03-18 | 1994-04-14 | Glyzinc Pharmaceuticals Limited | Treatment for gastric disorders |
| IT1269578B (it) * | 1994-04-22 | 1997-04-08 | Chiesi Farma Spa | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base. |
| US5750147A (en) * | 1995-06-07 | 1998-05-12 | Emisphere Technologies, Inc. | Method of solubilizing and encapsulating itraconazole |
| UA57734C2 (uk) | 1996-05-07 | 2003-07-15 | Пфайзер Інк. | Комплекси включення арилгетероциклічних солей |
| IL127955A0 (en) * | 1996-07-11 | 1999-11-30 | Farmarc Nederland Bv | Pharmaceutical composition containing acid addition salt of basic drug |
| GB9711643D0 (en) * | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| KR19990001564A (ko) * | 1997-06-16 | 1999-01-15 | 유충식 | 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제 |
| ATE214269T1 (de) * | 1997-06-27 | 2002-03-15 | Akzo Nobel Nv | Oral anzuwendende flüssige arzneilösung |
| US6077871A (en) * | 1997-11-26 | 2000-06-20 | Pfizer Inc. | Droloxifene pharmaceutical compositions |
| DK172860B1 (da) * | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
| JP2000080123A (ja) * | 1998-09-03 | 2000-03-21 | Toagosei Co Ltd | シアノアクリレート用硬化促進剤 |
| GB9822170D0 (en) * | 1998-10-13 | 1998-12-02 | Danbioyst Uk Ltd | Novel formulations of fexofenadine |
| FI982733L (fi) * | 1998-12-17 | 2000-06-18 | Orion Yhtymae Oyj | Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia |
| FI109332B (fi) | 1998-12-17 | 2002-07-15 | Orion Yhtymae Oyj | Toremifeenin liukoisia koostumuksia |
| US6740639B1 (en) * | 2000-03-29 | 2004-05-25 | Council Of Scientific & Industrial Research | Inclusion complees of a high potent opioid peptide, pharmaceutical compositions and method of treatment |
| GB0015239D0 (en) * | 2000-06-21 | 2000-08-16 | Biochemie Gmbh | Organic compounds |
| US6663897B2 (en) | 2001-02-06 | 2003-12-16 | Dsm Ip Assets B.V. | Oral itraconazole formulations and methods of making the same |
| JP2003063965A (ja) * | 2001-06-13 | 2003-03-05 | Otsuka Pharmaceut Factory Inc | 注射用シロスタゾール水性製剤 |
| AU2002365077A1 (en) * | 2001-09-19 | 2003-06-30 | Massachusetts Institute Of Technology | Methods and products related to non-viral transfection |
| US20050025791A1 (en) | 2002-06-21 | 2005-02-03 | Julius Remenar | Pharmaceutical compositions with improved dissolution |
| US7790905B2 (en) | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
| WO2003101392A2 (en) * | 2002-05-31 | 2003-12-11 | Transform Pharmaceuticals, Inc. | Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| US7446107B2 (en) | 2002-02-15 | 2008-11-04 | Transform Pharmaceuticals, Inc. | Crystalline forms of conazoles and methods of making and using the same |
| CA2477923C (en) | 2002-03-01 | 2021-02-23 | University Of South Florida | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| WO2004017897A2 (en) * | 2002-08-20 | 2004-03-04 | Bristol-Myers Squibb Company | Aripiprazole complex formulation and method |
| US7648678B2 (en) | 2002-12-20 | 2010-01-19 | Dako Denmark A/S | Method and system for pretreatment of tissue slides |
| US8183290B2 (en) | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
| US20050085446A1 (en) * | 2003-04-14 | 2005-04-21 | Babu M.K. M. | Fluoroquinolone formulations and methods of making and using the same |
| US7157446B2 (en) * | 2003-05-02 | 2007-01-02 | Bristol Myers Squibb Company | Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol |
| CN1515260B (zh) * | 2003-06-26 | 2010-05-05 | 沈阳药科大学 | 含hpcd的桂利嗪粉针剂和其固体制剂及其制备方法 |
| DK2239273T3 (da) | 2003-11-13 | 2013-12-09 | Hanmi Science Co Ltd | Farmaceutisk sammensætning, der omfatter en immunoglobulin Fc-region som en bærer |
| US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| EP1570862A1 (en) * | 2004-02-25 | 2005-09-07 | JPM - The Jordanian Pharmaceutical Manufacturing Co. Ltd. | Highly soluble binary cyclodextrin inclusion complexes |
| JP2007525502A (ja) * | 2004-02-26 | 2007-09-06 | トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド | コナゾール類の新規な結晶形態並びにそれらの製造および使用方法 |
| CN1997372B (zh) * | 2004-06-24 | 2010-06-02 | 西梯茜生命工学股份有限公司 | 包含依他康那唑的固态分散剂的制造方法及其医药组成物 |
| US20060105992A1 (en) * | 2004-11-08 | 2006-05-18 | Buchanan Charles M | Pharmaceutical formulations of cyclodextrins and selective estrogen receptor modulator compounds |
| US20060105045A1 (en) * | 2004-11-08 | 2006-05-18 | Buchanan Charles M | Cyclodextrin solubilizers for liquid and semi-solid formulations |
| DE102005041860A1 (de) * | 2005-09-02 | 2007-03-08 | Schering Ag | Nanopartikulärer Einschluss- und Ladungskomplex für pharmazeutische Formulierungen |
| WO2007047253A2 (en) * | 2005-10-11 | 2007-04-26 | Eastman Chemical Company | Pharmaceutical formulations of cyclodextrins and antifungal azole compounds |
| CN101990542A (zh) * | 2008-02-08 | 2011-03-23 | 德克萨斯大学董事会 | 环巴胺酒石酸盐及其用途 |
| CN101314045B (zh) * | 2008-05-09 | 2013-01-23 | 沈阳药科大学 | 桂利嗪的磺丁基醚-β-环糊精包合物及其制剂和制备方法 |
| AU2009266317B2 (en) | 2008-07-03 | 2013-12-05 | University Of Virginia Patent Foundation | Unit dosage of apadenoson |
| WO2010021750A2 (en) | 2008-08-21 | 2010-02-25 | The Johns Hopkins University | Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer |
| US11020363B2 (en) | 2009-05-29 | 2021-06-01 | Cydex Pharmaceuticals, Inc. | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same |
| CA2763365C (en) | 2009-05-29 | 2016-09-13 | Cydex Pharmaceuticals, Inc. | Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same |
| JP5803150B2 (ja) * | 2011-03-02 | 2015-11-04 | 三菱瓦斯化学株式会社 | ピロロキノリンキノンーシクロデキストリン包接体 |
| CN105744944B (zh) | 2013-09-09 | 2020-07-07 | 卡尼姆盖德治疗学公司 | 免疫系统调节器 |
| JP6552509B2 (ja) * | 2014-01-14 | 2019-07-31 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 選択的ａｔｐ阻害剤をカプセル化するシクロデキストリン組成物およびその使用 |
| WO2016072985A1 (en) | 2014-11-05 | 2016-05-12 | Halliburton Energy Services, Inc. | Delayed acid breaker systems for filtercakes |
| DK3265117T3 (da) | 2015-03-06 | 2021-02-08 | Canimguide Therapeutics Ab | Immunsystemmodulatorer og præparater |
| CN106539752B (zh) * | 2015-09-18 | 2019-10-29 | 成都康弘药业集团股份有限公司 | 一种含有阿立哌唑的口服溶液及其制备方法 |
| WO2017079563A1 (en) | 2015-11-06 | 2017-05-11 | The Johns Hopkins University | Methods of treating liver fibrosis by administering 3-bromopyruvate |
| US20230233572A1 (en) | 2020-06-11 | 2023-07-27 | Sentiss Pharma Private Limited | Ophthalmic compositions comprising a combination of fluoroquinolone antibacterial agent and an anti-inflammatory agent |
| KR102356618B1 (ko) * | 2021-11-17 | 2022-02-08 | 명지대학교 산학협력단 | 신규 포접복합체 및 이의 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU182217B (en) * | 1980-10-17 | 1983-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing inclusive complexes of cyclodextrines and strong inorganic oxyacids |
| JPS60185772A (ja) * | 1984-03-05 | 1985-09-21 | Mitsui Pharmaceut Inc | 安定なカルモフ−ル−β−シクロデキストリンの包接化合物 |
| US5091171B2 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
| JP2571199B2 (ja) * | 1987-11-25 | 1997-01-16 | 塩水港精糖株式会社 | 溶解性の高いサイクロデキストリンの製造方法 |
| US5646131A (en) * | 1994-02-22 | 1997-07-08 | The Arab Company For Drug Industries And Medical Applicances (Acdima) | Method for solubilizing drugs using cyclodextrins and carboxylic acids |
-
1993
- 1993-01-29 IT ITMI930141A patent/IT1263831B/it active IP Right Grant
-
1994
- 1994-01-26 AU AU59710/94A patent/AU691115B2/en not_active Ceased
- 1994-01-26 NZ NZ261115A patent/NZ261115A/en unknown
- 1994-01-26 DE DE69431747T patent/DE69431747D1/de not_active Expired - Lifetime
- 1994-01-26 KR KR1019950702913A patent/KR960700074A/ko active IP Right Grant
- 1994-01-26 CA CA002154874A patent/CA2154874A1/en not_active Abandoned
- 1994-01-26 AT AT94905707T patent/ATE228013T1/de not_active IP Right Cessation
- 1994-01-26 CZ CZ951943A patent/CZ284606B6/cs not_active IP Right Cessation
- 1994-01-26 EP EP94905707A patent/EP0681481B1/en not_active Expired - Lifetime
- 1994-01-26 WO PCT/EP1994/000205 patent/WO1994016733A1/en active IP Right Grant
- 1994-01-26 US US08/481,519 patent/US5855916A/en not_active Expired - Fee Related
- 1994-01-26 JP JP6516681A patent/JPH08508711A/ja not_active Ceased
- 1994-01-26 HU HU9502251A patent/HU218796B/hu not_active IP Right Cessation
- 1994-01-26 BR BR9406779A patent/BR9406779A/pt not_active Application Discontinuation
- 1994-01-27 ZA ZA94572A patent/ZA94572B/xx unknown
- 1994-01-27 IL IL10846094A patent/IL108460A/en not_active IP Right Cessation
-
1995
- 1995-07-27 FI FI953590A patent/FI953590L/fi unknown
- 1995-07-27 NO NO952981A patent/NO952981L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA94572B (en) | 1994-09-13 |
| FI953590L (fi) | 1995-09-14 |
| ITMI930141A0 (it) | 1993-01-29 |
| EP0681481A1 (en) | 1995-11-15 |
| DE69431747D1 (de) | 2003-01-02 |
| AU5971094A (en) | 1994-08-15 |
| BR9406779A (pt) | 1996-02-06 |
| NO952981D0 (no) | 1995-07-27 |
| CZ194395A3 (en) | 1996-01-17 |
| CA2154874A1 (en) | 1994-08-04 |
| WO1994016733A1 (en) | 1994-08-04 |
| KR960700074A (ko) | 1996-01-19 |
| US5855916A (en) | 1999-01-05 |
| FI953590A0 (fi) | 1995-07-27 |
| NZ261115A (en) | 1996-11-26 |
| ITMI930141A1 (it) | 1994-07-30 |
| JPH08508711A (ja) | 1996-09-17 |
| NO952981L (no) | 1995-07-27 |
| AU691115B2 (en) | 1998-05-07 |
| CZ284606B6 (cs) | 1999-01-13 |
| ATE228013T1 (de) | 2002-12-15 |
| HU9502251D0 (en) | 1995-09-28 |
| IL108460A0 (en) | 1994-04-12 |
| EP0681481B1 (en) | 2002-11-20 |
| IT1263831B (it) | 1996-09-04 |
| HU218796B (hu) | 2000-12-28 |
| IL108460A (en) | 1999-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL108460A0 (en) | Highly soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrin | |
| HK1002017A1 (en) | Lyospheres comprising gonadotropin | |
| NO954215D0 (no) | Transdermal medikament-fremstilling | |
| ATE224360T1 (de) | Adamantan-derivate | |
| MY112915A (en) | Multiple unit tableted dosage form 1 | |
| IL124674A0 (en) | Piperazine derivatives pharmaceutical compositions containing the same and use thereof | |
| PT1036058E (pt) | Deribvados de adamantano | |
| AU1482102A (en) | Complexes of phosphate derivatives | |
| AU2307695A (en) | High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base | |
| HUT68239A (en) | Process for producing inclusion complexes of nimesulide alkali salts with cyclodextrins or cyclodextrin derivatives and pharmaceutical preparations containing them | |
| AU8332791A (en) | Oral pharmaceutical compositions containing melatonin | |
| MX9708394A (es) | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. | |
| AU692534B2 (en) | Slow-release tablet containing diclofenac-na | |
| IL115740A0 (en) | A childproof package for active substance patches and a process for the production thereof | |
| GEP20012518B (en) | Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine | |
| CZ20022240A3 (cs) | Mannichovy báze substituovaného 1-a 2-naftolu | |
| AU1459192A (en) | Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them | |
| GR1002670B (el) | Συμπλοκα εγκλισεως και φαρμακευτικες συνθεσεις οι οποιες τα περιεχουν. | |
| AU5269696A (en) | Anellated beta-carbolines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |